SN
Sittner & Nelson’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $242K | Buy |
4,970
+580
| +13% | +$28.2K | 0.1% | 127 |
|
|
2025
Q1 | $149K | Hold |
4,390
| – | – | 0.06% | 160 |
|
|
2024
Q4 | $173K | Buy |
4,390
+653
| +17% | +$25.7K | 0.07% | 141 |
|
|
2024
Q3 | $176K | Buy |
3,737
+190
| +5% | +$8.93K | 0.08% | 139 |
|
|
2024
Q2 | $192K | Sell |
3,547
-300
| -8% | -$16.2K | 0.09% | 118 |
|
|
2024
Q1 | $262K | Buy |
3,847
+250
| +7% | +$17K | 0.13% | 100 |
|
|
2023
Q4 | $225K | Sell |
3,597
-90
| -2% | -$5.63K | 0.12% | 104 |
|
|
2023
Q3 | $167K | Buy |
3,687
+150
| +4% | +$6.81K | 0.1% | 117 |
|
|
2023
Q2 | $199K | Hold |
3,537
| – | – | 0.11% | 107 |
|
|
2023
Q1 | $160K | Buy |
3,537
+130
| +4% | +$5.88K | 0.09% | 130 |
|
|
2022
Q4 | $138K | Sell |
3,407
-20
| -0.6% | -$813 | 0.08% | 140 |
|
|
2022
Q3 | $224K | Hold |
3,427
| – | – | 0.15% | 103 |
|
|
2022
Q2 | $208K | Hold |
3,427
| – | – | 0.14% | 101 |
|
|
2022
Q1 | $215K | Buy |
3,427
+700
| +26% | +$43.9K | 0.12% | 99 |
|
|
2021
Q4 | $207K | Buy |
2,727
+210
| +8% | +$15.9K | 0.12% | 99 |
|
|
2021
Q3 | $282K | Buy |
2,517
+887
| +54% | +$99.4K | 0.18% | 80 |
|
|
2021
Q2 | $264K | Buy |
1,630
+430
| +36% | +$69.6K | 0.19% | 76 |
|
|
2021
Q1 | $146K | Buy |
+1,200
| New | +$146K | 0.11% | 105 |
|